Sign in

CIK 0001846253

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

OmniAb, Inc.

Sign in to watch
Ticker
OABI
Exchange
Nasdaq
Industry
Services-Commercial Physical & Biological Research
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 510-250-7800
Business address
5980 HORTON STREET, SUITE 600, EMERYVILLE, CA, 94608
Former names
Avista Public Acquisition Corp. II

Securities

  • OABI Common Stock Nasdaq
  • OABIW Warrant Nasdaq
  1. 4 Open-market buy EVP, Finance and CFO bought 10,000 shares at $2.81 ($28,100)
  2. 3/A Insider 3/A
  3. 4 Open-market buy Director bought 36,000 shares at an average $2.82 ($101,397)
  4. 4 Open-market buy Director bought 30,000 shares at $3.10 ($92,928)
  5. 4 Open-market buy Director bought 43,000 shares at $2.77 ($119,110)
  6. 3 Insider Initial Statement of Ownership
  7. 4 Open-market buy President & CEO bought 100,000 shares at $2.76 ($276,160)
  8. 4 Grant or award Director acquired 25,226 shares (grant or award)
  9. 4 Grant or award Berkman Charles S acquired 353,716 shares (grant or award)
  10. 4 Grant or award Director acquired 37,437 shares (grant or award)
  11. 4 Exercise or conversion Director acquired 246,648 shares (option exercise)
  12. 4 Grant or award Director acquired 172,512 shares (grant or award)
  13. 4 Grant or award EVP, Finance and CFO acquired 160,062 shares (grant or award)
  14. 4 Grant or award President & CEO acquired 1,305,350 shares (grant or award)
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 8 of 9 · 174 filings